AusPAR: Blinatumomab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Blinatumomab [PDF, 555.96 KB]

AusPAR: Blinatumomab [Word, 254.3 KB]

Attachment: Product Information: Blinatumomab [PDF, 302.57 KB]

Attachment: Product Information: Blinatumomab [Word, 229.15 KB]

Attachment: Extract from Clinical Evaluation Report: Blinatumomab [PDF, 2.04 MB]

Attachment: Extract from Clinical Evaluation Report: Blinatumomab [Word, 2.23 MB]

Device/Product Name

Blincyto

Active ingredients

Blinatumomab (rch)

AusPAR Date

7 February 2018

Published

9 February 2018

Submission Number

PM-2014-03864-1-4

Submission Type

New chemical entity

Decision

Approved